El Combivir Genérico está dentro de un grupo de medicamentos llamados inhibidores de la transcriptasa inversa. Se utiliza combinado con otros medicamentos para tratar la infección por VIH. Más informaión »
Ya recibí mi paquete, tuve un pequeño problema - como estaba previsto el cartero debia entregarlo en mi domicilio pero el paquete era demasiado grande y por ello les pedi que lo entregaran en mi oficina ya que no hay nadie en casa. Gracias por un buen servicio.
.
- Jan
Nuestra página de facturación está certificada por:
Aurobindo Pharma receives final approval for Lamivudine+Zidovudine Tablets - Equity Bulls
Zee NewsAurobindo Pharma receives final approval for Lamivudine+Zidovudine TabletsEquity BullsAurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch.
Aurobindo gets USFDA nod for anti-HIV drugs - Hindu Business Line
Aurobindo gets USFDA nod for anti-HIV drugsHindu Business LineAurobindo Pharma Ltd has received final approval from the US Food and Drug Administration to manufacture and market Lamivudine and Zidovudine tablets.
Patent expires of landmark HIV drug Combivir - U-T San Diego
Patent expires of landmark HIV drug CombivirU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.
South Africa exceeds 2007-11 treatment targets by 50% - aidsmap
South Africa exceeds 2007-11 treatment targets by 50%aidsmapCrude estimates of numbers of public sector patients on treatment in each quarter were calculated according to lamivudine (3TC, Epivir) sales figures from Aspen Pharmacare, which supplied 80% of lamivudine to the public sector until recently.
LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego
LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.